Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

HIV Infection

Free Subscription 17.05.2021 8 AIDS 1 AIDS Res Hum Retroviruses 1 Am J Epidemiol 2 Am J Med 2 Antimicrob Agents Chemother 1 Blood 5 Clin Infect Dis 2 HIV Med 7 J Acquir Immune Defic Syndr 3 J Infect Dis 1 J Med Virol 5 J Virol 3 Pediatr Infect Dis J 1 Pediatrics 3 PLoS Med 16 PLoS One 1 PLoS Pathog 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. DHAIRYAWAN R, Okhai H, Hill T, Sabin CA, et al
   Differences in HIV clinical outcomes amongst heterosexuals in the United Kingdom by ethnicity.
   AIDS. 2021 May 10. pii: 00002030-900000000-96411.
   PubMed         Abstract available
   
   
2. HAMADY A, Cooke GS, Garvey LJ
   Identification of hepatitis delta superinfection when investigating transaminitis in HIV/HBV coinfection.
   AIDS. 2021 May 10. pii: 00002030-900000000-96410.
   PubMed         Abstract available
   
   
3. CHADWICK D, Forbes G, Lawrence C, Lorrimer S, et al
   Using an electronic health record alert to prompt blood-borne virus testing in primary care.
   AIDS. 2021 May 10. pii: 00002030-900000000-96408.
   PubMed         Abstract available
   
   
4. PATHELA P, Jamison K, Braunstein SL, Borges CM, et al
   Initiating antiretroviral treatment for newly diagnosed HIV patients in sexual health clinics greatly improves timeliness of viral suppression.
   AIDS. 2021 May 10. pii: 00002030-900000000-96407.
   PubMed         Abstract available
   
   
5. MACHINGURA F, Chabata S, Busza J, Jamali G, et al
   Potential reduction in female sex workers' risk of contracting HIV during Covid-19.
   AIDS. 2021 May 7. pii: 00002030-900000000-96406.
   PubMed         Abstract available
   
   
6. ROYSTON L, Isnard S, Calmy A, Routy JP, et al
   Kaposi sarcoma in ART-treated people living with HIV: A wake-up call for research on HHV-8.
   AIDS. 2021 May 5. pii: 00002030-900000000-96414.
   PubMed        
   
   
7. GARBER DA, Guenthner P, Mitchell J, Ellis S, et al
   Broadly neutralizing antibody-mediated protection of macaques against repeated intravenous exposures to simian-human immunodeficiency virus.
   AIDS. 2021 May 5. pii: 00002030-900000000-96412.
   PubMed         Abstract available
   
   
8. GOSENS KCM, van der Zee RP, van Heukelom MLS, Jongen VW, et al
   HPV vaccination to prevent recurrence of Anal Intraepithelial Neoplasia in HIV+ MSM: a randomised, placebo-controlled multicentre trial.
   AIDS. 2021 May 5. pii: 00002030-900000000-96413.
   PubMed         Abstract available
   
   

   
   AIDS Res Hum Retroviruses

9. LATINI A, Dona MG, Giuliani M, Ancona C, et al
   HIV viral load trends during the COVID-19 pandemic in a reference center for HIV in Rome, Italy.
   AIDS Res Hum Retroviruses. 2021 May 8. doi: 10.1089/AID.2021.0044.
   PubMed         Abstract available
   
   

   
   Am J Epidemiol

10. MOLLAN KR, Pence BW, Xu S, Edwards JK, et al
    Transportability from Randomized Trials to Clinical Care: On Initial HIV Treatment with Efavirenz and Suicidal Thoughts or Behaviors.
    Am J Epidemiol. 2021 May 10. pii: 6273328. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Am J Med

11. ORKOULAS-RAZIS D, Traver E, Merechi F, Saleeb P, et al
    Clinical Communication to the Editor: Pancytopenia in a Cameroonian patient with AIDS.
    Am J Med. 2021 May 11. pii: S0002-9343(21)00305.
    PubMed        
    
    
12. SPEZIA-LINDNER NJ, Kondapi D, DiNardo AR, Ramaswami R, et al
    The Importance of Early Recognition of KSHV-mediated Syndromes: A Case Report.
    Am J Med. 2021 May 11. pii: S0002-9343(21)00304.
    PubMed        
    
    

    
    Antimicrob Agents Chemother

13. WASSERMAN S, Davis A, Stek C, Chirehwa M, et al
    Plasma pharmacokinetics of high dose oral versus intravenous rifampicin in patients with tuberculous meningitis: a randomized controlled trial.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.00140.
    PubMed         Abstract available
    
    
14. NGUYEN NTQ, Gras E, Tran ND, Nguyen NNY, et al
    Pseudomonas aeruginosa Ventilator-Associated Pneumonia Rabbit Model for Preclinical Drug Development.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.02724.
    PubMed         Abstract available
    
    

    
    Blood

15. KUEHN HS, Niemela JE, Stoddard J, Mannurita SC, et al
    Germline IKAROS dimerization haploinsufficiency causes hematologic cytopenias and malignancies.
    Blood. 2021;137:349-363.
    PubMed         Abstract available
    
    

    
    Clin Infect Dis

16. PEREZ F, Colindres RV, Wilson BM, Saade E, et al
    The Desirability of Outcome Ranking for the Management of Antimicrobial Therapy (DOOR MAT) Reveals Improvements in the Treatment of Bloodstream Infection Caused by Escherichia coli and Klebsiella pneumoniae in Patients from the Veterans Health Adminis
    Clin Infect Dis. 2021 May 12. pii: 6274459. doi: 10.1093.
    PubMed         Abstract available
    
    
17. DENNIS AM, Cressman A, Pasquale D, Frost SDW, et al
    Intersection of Syphilis and HIV Networks to Identify Opportunities to Enhance HIV Prevention.
    Clin Infect Dis. 2021 May 12. pii: 6274541. doi: 10.1093.
    PubMed         Abstract available
    
    
18. MOMPLAISIR F, Hussein M, Kacanek D, Brady K, et al
    Perinatal Depressive Symptoms, HIV Suppression, and the Underlying Role of ART Adherence: A Longitudinal Mediation Analysis in the IMPAACT P1025 Cohort.
    Clin Infect Dis. 2021 May 13. pii: 6274991. doi: 10.1093.
    PubMed         Abstract available
    
    
19. ERLANDSON KM, Carter CC, Melbourne K, Brown TT, et al
    Weight Change Following Antiretroviral Therapy Switch in People with Viral Suppression: Pooled Data from Randomized Clinical Trials.
    Clin Infect Dis. 2021 May 14. pii: 6275565. doi: 10.1093.
    PubMed         Abstract available
    
    
20. PALEFSKY JM, Lensing SY, Belzer M, Lee J, et al
    High prevalence of anal high-grade squamous intraepithelial lesions, and prevention through human papillomavirus vaccination, in young men who have sex with men living with HIV.
    Clin Infect Dis. 2021 May 15. pii: 6276233. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    HIV Med

21. VORA J, Velhal S, Sinha S, Patel V, et al
    Bioactive phytocompound mulberroside C and endophytes of Morus alba as potential inhibitors of HIV-1 replication: a mechanistic evaluation.
    HIV Med. 2021 May 14. doi: 10.1111/hiv.13116.
    PubMed         Abstract available
    
    
22. GILL MJ, Powell M, Vu Q, Krentz HB, et al
    Economic impact on direct healthcare costs of missing opportunities for diagnosing HIV within healthcare settings.
    HIV Med. 2021 May 12. doi: 10.1111/hiv.13121.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

23. JOHNSON KA, Okochi H, Glidden DV, Gandhi M, et al
    Brief Report: No Difference in Urine Tenofovir Levels in Patients Living with HIV on Unboosted vs Dose-Adjusted Boosted Tenofovir Alafenamide.
    J Acquir Immune Defic Syndr. 2021 May 12. pii: 00126334-900000000-95879.
    PubMed         Abstract available
    
    
24. FOX MP, Pascoe S, Huber AN, Murphy J, et al
    Short-term Outcomes from a Cluster Randomized Evaluation of Adherence Clubs as Part of Differentiated HIV Care in South Africa.
    J Acquir Immune Defic Syndr. 2021 May 12. pii: 00126334-900000000-95880.
    PubMed         Abstract available
    
    
25. HESELTINE T, Murray S, Ortega-Martorell S, Olier I, et al
    Associations of Hepatosteatosis with Cardiovascular Disease in HIV Positive and HIV Negative Patients: The Liverpool HIV-Heart Project.
    J Acquir Immune Defic Syndr. 2021 May 8. pii: 00126334-900000000-95882.
    PubMed         Abstract available
    
    
26. JIAMSAKUL A, Boyd M, Choi JY, Edmiston N, et al
    Trends in follow-up visits among people living with HIV - results from the TREAT Asia and Australian HIV Observational Databases (TAHOD and AHOD).
    J Acquir Immune Defic Syndr. 2021 May 10. pii: 00126334-900000000-95883.
    PubMed         Abstract available
    
    
27. DIAS JP, Haberlen SA, Dobs AS, Lake JE, et al
    Longitudinal changes in sex hormone-binding globulin in men with HIV.
    J Acquir Immune Defic Syndr. 2021 May 10. pii: 00126334-900000000-95884.
    PubMed         Abstract available
    
    
28. DRAIN PK, Galagan SR, Govere S, Krows M, et al
    Laboratory Reflex and Clinic-based Point-of-care Cryptococcal Antigen Screening for Preventing Meningitis and Mortality among People Living with HIV.
    J Acquir Immune Defic Syndr. 2021 May 10. pii: 00126334-900000000-95885.
    PubMed         Abstract available
    
    
29. GRAHAM SM, Maqungo S, Laubscher M, Ferreira N, et al
    Fracture healing in patients with human immunodeficiency virus in South Africa: a prospective cohort study.
    J Acquir Immune Defic Syndr. 2021 May 10. pii: 00126334-900000000-95886.
    PubMed         Abstract available
    
    

    
    J Infect Dis

30. BRUCE-BRAND C, Schubert PT, Wright CA
    HIV, placental pathology and birth outcomes - a brief overview.
    J Infect Dis. 2021 May 14. pii: 6275456. doi: 10.1093.
    PubMed         Abstract available
    
    
31. GABRIELAITE M, Bennedbaek M, Zucco AG, Ekenberg C, et al
    Human immunotypes impose selection on viral genotypes through viral epitope specificity.
    J Infect Dis. 2021 May 11. pii: 6273783. doi: 10.1093.
    PubMed         Abstract available
    
    
32. GUERRERO-MARTIN SM, Rubin LH, McGee KM, Shirk EN, et al
    Psychosocial Stress Alters the Immune Response and Results in Higher Viral Load During Acute SIV Infection in a Pigtailed Macaque Model of HIV.
    J Infect Dis. 2021 May 10. pii: 6273219. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

33. TING Y, Liang S, Yang S, Lin Y, et al
    Phylogenetic characteristics of HIV among female cross-border travelers in Yunnan Province between 2003 and 2012.
    J Med Virol. 2021 May 11. doi: 10.1002/jmv.27079.
    PubMed         Abstract available
    
    

    
    J Virol

34. TAUZIN A, Ortiz AE, Blake O, Soundaramourty C, et al
    Differential inhibition of HIV replication by the 12 interferon-alpha subtypes.
    J Virol. 2021 May 12. pii: JVI.02311-20. doi: 10.1128/JVI.02311.
    PubMed         Abstract available
    
    
35. RUBIO AA, Filsinger Interrante MV, Bell BN, Brown CL, et al
    A derivative of the D5 monoclonal antibody that targets the gp41 N-heptad repeat of HIV-1 with broad tier-2 neutralizing activity.
    J Virol. 2021 May 12. pii: JVI.02350-20. doi: 10.1128/JVI.02350.
    PubMed         Abstract available
    
    
36. REN Y, Huang SH, Macedo AB, Ward AR, et al
    Selective BCL-XL Antagonists Eliminate Infected Cells from a Primary Cell Model of HIV Latency but not from Ex Vivo Reservoirs.
    J Virol. 2021 May 12. pii: JVI.02425-20. doi: 10.1128/JVI.02425.
    PubMed         Abstract available
    
    
37. PIETRANTONI G, Gaete-Argel A, Herrera-Rojo D, Ibarra-Karmy R, et al
    Dynein light chain Dynlrb2 is essential for Murine leukemia virus traffic and nuclear entry.
    J Virol. 2021 May 12. pii: JVI.00170-21. doi: 10.1128/JVI.00170.
    PubMed         Abstract available
    
    
38. OSTERMANN PN, Ritchie A, Ptok J, Schaal H, et al
    Let it go: HIV-1 cis-acting repressive sequences.
    J Virol. 2021 May 12. pii: JVI.00342-21. doi: 10.1128/JVI.00342.
    PubMed         Abstract available
    
    

    
    Pediatr Infect Dis J

39. TUKEI VJ, Hoffman HJ, Greenberg L, Thabelo R, et al
    Adverse Pregnancy Outcomes Among HIV-positive Women in the Era of Universal Antiretroviral Therapy Remain Elevated Compared With HIV-negative Women.
    Pediatr Infect Dis J. 2021 May 7. pii: 00006454-900000000-95812.
    PubMed         Abstract available
    
    
40. FINOCCHARIO-KESSLER S, Wexler C, Brown M, Goggin K, et al
    Piloting the Feasibility and Preliminary Impact of Adding Birth HIV Polymerase Chain Reaction Testing to the Early Infant Diagnosis Guidelines in Kenya.
    Pediatr Infect Dis J. 2021 May 7. pii: 00006454-900000000-95811.
    PubMed         Abstract available
    
    
41. NJUGUNA HN, Zaki SR, Roberts DJ, Rogena EA, et al
    Postmortem Study of Cause of Death Among Children Hospitalized With Respiratory Illness in Kenya.
    Pediatr Infect Dis J. 2021 May 4. pii: 00006454-900000000-95817.
    PubMed         Abstract available
    
    

    
    Pediatrics

42. CUMMINGS L, Tucker M, Gibson M, Myers A, et al
    Rare Genetic Variants in Immune Genes and Neonatal Herpes Simplex Viral Infections.
    Pediatrics. 2021;147.
    PubMed         Abstract available
    
    

    
    PLoS Med

43. INDRAVUDH PP, Fielding K, Kumwenda MK, Nzawa R, et al
    Effect of community-led delivery of HIV self-testing on HIV testing and antiretroviral therapy initiation in Malawi: A cluster-randomised trial.
    PLoS Med. 2021;18:e1003608.
    PubMed         Abstract available
    
    
44. SATINSKY EN, Kakuhikire B, Baguma C, Rasmussen JD, et al
    Adverse childhood experiences, adult depression, and suicidal ideation in rural Uganda: A cross-sectional, population-based study.
    PLoS Med. 2021;18:e1003642.
    PubMed         Abstract available
    
    
45. SHADE SB, Kirby VB, Stephens S, Moran L, et al
    Outcomes and costs of publicly funded patient navigation interventions to enhance HIV care continuum outcomes in the United States: A before-and-after study.
    PLoS Med. 2021;18:e1003418.
    PubMed         Abstract available
    
    

    
    PLoS One

46. LOCH AP, Rocha SQ, Fonsi M, de Magalhaes Caraciolo JM, et al
    Improving the continuum of care monitoring in Brazilian HIV healthcare services: An implementation science approach.
    PLoS One. 2021;16:e0250060.
    PubMed         Abstract available
    
    
47. ROBERTS DA, Abera S, Basualdo G, Kerani RP, et al
    Barriers to accessing preventive health care among African-born individuals in King County, Washington: A qualitative study involving key informants.
    PLoS One. 2021;16:e0250800.
    PubMed         Abstract available
    
    
48. DA CRUZ MM, Cota VL, Lentini N, Bingham T, et al
    Comprehensive approach to HIV/AIDS testing and linkage to treatment among men who have sex with men in Curitiba, Brazil.
    PLoS One. 2021;16:e0249877.
    PubMed         Abstract available
    
    
49. BUGGISCH P, Heiken H, Mauss S, Weber B, et al
    Barriers to initiation of hepatitis C virus therapy in Germany: A retrospective, case-controlled study.
    PLoS One. 2021;16:e0250833.
    PubMed         Abstract available
    
    
50. JIN Y, Assanangkornchai S, Du Y, Liu J, et al
    Measuring and explaining inequality of continuous care for people living with HIV receiving antiretroviral therapy in Kunming, China.
    PLoS One. 2021;16:e0251252.
    PubMed         Abstract available
    
    
51. FOUDA MBARGA N, Epee E, Mbarga M, Ouamba P, et al
    Clinical profile and factors associated with COVID-19 in Yaounde, Cameroon: A prospective cohort study.
    PLoS One. 2021;16:e0251504.
    PubMed         Abstract available
    
    
52. SEVILLANO N, Green EM, Votteler J, Kim DY, et al
    Identification of recombinant Fabs for structural and functional characterization of HIV-host factor complexes.
    PLoS One. 2021;16:e0250318.
    PubMed         Abstract available
    
    
53. GISSLEN M, Keating SM, Spudich S, Arechiga V, et al
    Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression.
    PLoS One. 2021;16:e0250987.
    PubMed         Abstract available
    
    
54. ABBA A, Fokam J, Kamgaing RS, Yimga JF, et al
    Correlation between the immuno-virological response and the nutritional profile of treatment-experienced HIV-infected patients in the East region of Cameroon.
    PLoS One. 2021;16:e0229550.
    PubMed         Abstract available
    
    
55. 
    Correction: Higher plasma drug levels in elderly people living with HIV treated with darunavir.
    PLoS One. 2021;16:e0251856.
    PubMed         Abstract available
    
    
56. PARK MH, Suhalim JL, Elmastour F, Singha SK, et al
    Non-linear optical imaging of atherosclerotic plaques in the context of SIV and HIV infection prominently detects crystalline cholesterol esters.
    PLoS One. 2021;16:e0251599.
    PubMed         Abstract available
    
    
57. ROSS J, Ingabire C, Umwiza F, Gasana J, et al
    How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda-A qualitative study.
    PLoS One. 2021;16:e0251645.
    PubMed         Abstract available
    
    
58. AEMRO A, Wassie M, Chekol B
    Incidence and predictors of mortality within the first year of antiretroviral therapy initiation at Debre-Markos Referral Hospital, Northwest Ethiopia: A retrospective follow up study.
    PLoS One. 2021;16:e0251648.
    PubMed         Abstract available
    
    
59. BESUTTI G, Pellegrini M, Ottone M, Cantini M, et al
    The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients.
    PLoS One. 2021;16:e0251768.
    PubMed         Abstract available
    
    
60. JORNS-PRESENTATI A, Napp AK, Dessauvagie AS, Stein DJ, et al
    The prevalence of mental health problems in sub-Saharan adolescents: A systematic review.
    PLoS One. 2021;16:e0251689.
    PubMed         Abstract available
    
    
61. KOUSIGNIAN I, Sautereau A, Vigouroux C, Cros A, et al
    Diagnosis, risk factors and management of diabetes mellitus in HIV-infected persons in France: A real-life setting study.
    PLoS One. 2021;16:e0250676.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

62. COOMER CA, Carlon-Andres I, Iliopoulou M, Dustin ML, et al
    Correction: Single-cell glycolytic activity regulates membrane tension and HIV-1 fusion.
    PLoS Pathog. 2021;17:e1009584.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

63. MORVAN MG, Teque F, Ye L, Moreno ME, et al
    Genetically edited CD34(+) cells derived from human iPS cells in vivo but not in vitro engraft and differentiate into HIV-resistant cells.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: